RayzeBio Soars; Bristol Myers to pay $4.1 billion in second major purchase in three days
RayzeBio shares nearly doubled in early trading Tuesday after the cancer drug specialists agreed to a $4.1 billion acquisition by ...
Tag: RayzeBio
Recommended.
